Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital-Reference-Cited by-同舟云学术

Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital

Published:2016-08-05 Issue:1 Volume:16 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Kimura Muneyoshi,Araoka Hideki,Yoshida Atsushi,Yamamoto Hisashi,Abe Masahiro,Okamoto Yuki,Yuasa Mitsuhiro,Kaji Daisuke,Kageyama Kosei,Nishida Aya,Ishiwata Kazuya,Takagi Shinsuke,Yamamoto Go,Asano-Mori Yuki,Uchida Naoyuki,Hishinuma Akira,Izutsu Koji,Wake Atsushi,Taniguchi Shuichi,Yoneyama Akiko

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-016-1692-y

Reference30 articles.

1. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious disease society of America. Clin Infect Dis. 2011;52(4):427–31.

2. Guthrie KA, Yong M, Frieze D, Corey L, Fredricks DN. The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2010;45(4):675–81.

3. Busca A, Cavecchia I, Locatelli F, D’Ardia S, De Rosa FG, Marmont F, et al. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis. Transpl Infect Dis. 2012;14(1):40–8.

4. Blennow O, Liunqman P, Sparrelid E, Mattsson J, Remberger M. Incidence, risk factors, and outcome of blood stream infections during the pre-engraftment phase in 512 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis. 2014;16(1):106–14.

5. Seo SK, Xiao K, Haung YT, Jongwutiwes U, Chung D, Maloy M, et al. Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: A 12-year single institution study. J Infect. 2014;69(4):341–51.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy;Journal of Antimicrobial Chemotherapy;2024-07-08

2. Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies;Journal of Oncology Pharmacy Practice;2023-11-19

3. Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients;Transplant Infectious Disease;2023-10-20

4. Improving Oral Health and Modulating the Oral Microbiome to Reduce Bloodstream Infections from Oral Organisms in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Recipients: A Randomized Controlled Trial;Biology of Blood and Marrow Transplantation;2020-09

5. Bloodstream infection by multidrug‐resistant Streptococcus oralis in a leukemic patient with febrile neutropenia after hematopoietic stem cell transplantation;Transplant Infectious Disease;2020-01-20